missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. FKBP12 Antibody, Novus Biologicals™
  7. 18631126

FKBP12 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP2-99149-50ul

 View more versions of this product

Product Code. 18631126

  • 227.00€ / 50µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

FKBP12 Polyclonal antibody specifically detects FKBP12 in Human samples. It is validated for Western Blot, ELISA
TRUSTED_SUSTAINABILITY
Specifications

Specifications

FKBP12
Polyclonal
Western Blot 1:500-1:2000, ELISA 1:1000-1:2000
12 kDa FKBP, EC 5.2.1.8, FK506 binding protein 1A, 12kDa, FK506-binding protein 1A, FKBP1, FKBP12C, FKBP12FKBP12-Exip3, FKBP-12T-cell, 12-kD, FKBP-1A, peptidyl-prolyl cis-trans isomerase FKBP1A, PPIase FKBP1A, protein kinase C inhibitor 2, rotamase
Produced in rabbits immunized with purified, recombinant Human FKBP12 (Accession#: NP_463460; Met 1-Glu 108)
50 μg
Autophagy, Cancer, mTOR Pathway
2280
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG
Western Blot, ELISA
Unconjugated
0.2 um filtered solution in PBS
Rabbit
Antigen and protein A Affinity-purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.